Control of hypertension 5 years after stroke in the North East Melbourne stroke incidence study

Hypertension

Volumn 48, Issue 2, 2006, Pages 260-265

  Paul, Seana L ^a,c,e   Thrift, Amanda G ^a,b,c,d  

^a FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^b AUSTIN HEALTH   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d MONASH UNIVERSITY   (Australia)

^e HEIDELBERG REPATRIATION HOSPITAL   (Australia)

Author keywords

Blood pressure; Epidemiology; Hypertension, detection and control; Prospective studies; Stroke

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; METHYLDOPA;

AGED; ANAMNESIS; ARTICLE; AUSTRALIA; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DIET; DIET THERAPY; DRUG USE; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECURRENT DISEASE; STATISTICAL ANALYSIS; STROKE;

AGED; ANTIHYPERTENSIVE AGENTS; AUSTRALIA; BLOOD PRESSURE; CEREBROVASCULAR ACCIDENT; COMORBIDITY; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; INCIDENCE; MALE; PREVALENCE; PROSPECTIVE STUDIES; RECURRENCE; SURVIVAL ANALYSIS; SURVIVORS; TREATMENT OUTCOME; URBAN POPULATION;

EID: 33748202165     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000230610.81947.04     Document Type: Article

References (20)

1. PROGRESS collaborative group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet. 2001;358:1033-1041.
2. Rashid P, Leonardi-Bee J, Bath P. Blood pressure reduction and secondary prevention of stroke and other vascular events: a systematic review. Stroke. 2003;34:2741-2748.
3. World Health Organisation-International Society of Hypertension. 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee. J Hypertens. 1999;17:151-183.
4. Hillen T, Dundas R, Lawrence E, Stewart JA, Rudd AG, Wolfe CDA. Antithrombotic and antihypertensive management 3 months after ischemic stroke: a prospective study in an inner city population. Stroke. 2000;31:469-475.
5. Mouradian MS, Majumdar SR, Senthilselvan A, Khan K, Shuaib A. How well are hypertension, hyperlipidemia, diabetes, and smoking managed after a stroke or transient ischemic attack? Stroke. 2002;33:1656-1659.
6. Thrift AG, Dewey HM, Sturm JW, Paul SL, Gilligan AK, Srikanth VK, Macdonell RA, McNeil JJ, Macleod MR, Donnan GA. Greater incidence of both fatal and nonfatal strokes in disadvantaged areas. The North East Melbourne Stroke Incidence Study (NEMESIS). Stroke. 2006;37:877-882.
7. Sudlow C, Warlow C. Comparing stroke incidence worldwide: what makes studies comparable? Stroke. 1996;27:550-558.
8. Malmgren R, Warlow C, Bamford J, Sandercock P. Geographical and secular trends in stroke incidence. Lancet. 1987;2:1196-1200.
9. Hatano S. Experience from a multicentre stroke register: a preliminary report. Bull World Health Organ. 1976;54:541-553.
10. Brott T, Adams HP Jr, Olinger CP, Marler JR, Barsan WG, Biller J, Spilker J, Holleran R, Eberle R, Hertzberg V. Measurements of acute cerebral infarction: a clinical examination scale. Stroke. 1989;20:864-870.
11. Australian Bureau of Statistics. Australian Standard Classification of Occupations, Second Edition, and ASCO Coder. Canberra, Australia: ABS; 1997.
12. National Health and Medical Research Council. Australian Alcohol Guidelines: Health Benefits and Risks. Canberra, Australia: National Health and Medical Research Council; 2001.
13. Department of Health and Aging and The National Health and Medical Research Council. National Physical Activity Guidelines for Australians. Canberra, Australia: The National Health and Medical Research Council; 1999.
14. British Hypertension Society. Blood Pressure Measurement: Recommendations of the British Hypertension Society. Aberdeen, United Kingdom: Medi-CAL Unit, University of Aberdeen; 1999. Available at: http://www.abdn.ac.uk/medical/bhs/ booklet/proced.htm. Accessed January 12, 2006.
15. Sappok T, Faulstich A, Stuckert E, Kruck H, Marx P, Koennecke H-C. Compliance with secondary prevention of ischemic stroke: a prospective evaluation. Stroke. 2001;32:1884-1889.
16. Joseph LN, Babikian VL, Allen NC, Winter MR. Risk factor modification in stroke prevention: the experience of a stroke clinic. Stroke. 1999;30:16-20.
17. Wolf-Maier K, Cooper RS, Banegas JR, Giampaoli S, Hense HW, Joffres M, Kastarinen M, Poulter N, Primatesta P, Rodriguez-Artalejo F, Stegmayr B, Thamm M, Tuomilehto J, Vanuzzo D, Vescio F. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA. 2003;289:2363-2369.
18. Di Bari M, Salti F, Nardi M, Pahor M, De Fusco C, Tonon E, Ungar A, Pini R, Masotti G, Marchionni N. Undertreatment of hypertension in community-dwelling older adults: a drug-utilization study in Dicomano, Italy. J Hypertens. 1999;17:1633-1640.
19. van Rossum CT, van de Mheen H, Witteman JC, Hofman A, Mackenbach JP, Grobbee DE. Prevalence, treatment, and control of hypertension by sociodemographic factors among the Dutch elderly. Hypertension. 2000;35:814-821.
20. Klungel OH, de Boer A, Paes AH, Seidell JC, Nagelkerke NJ, Bakker A. Undertreatment of hypertension in a population-based study in the Netherlands. J Hypertens. 1998;16:1371-1378.